Furthermore, HGF plays a definitive role in both intrinsic and acquired resistance to anti-tumor drug by increasing the PI3K/AKT signaling, an important survival pathway in NSCLC [8]. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.